R21/Matrix-M vaccine offers significant protection against malaria in African children
1. The R21/Matrix-M vaccine had a high 12-month efficacy across seasonal and standard sites. 2. The reduction in malarial infection ...
1. The R21/Matrix-M vaccine had a high 12-month efficacy across seasonal and standard sites. 2. The reduction in malarial infection ...
1. Patients in the primaquine group reported a significant reduction in parasitemia risk at day 63 compared to those in ...
1. Adverse pregnancy outcomes were less frequent among patients in the sulfadoxine-pyrimethamine group. 2. Differences in adverse pregnancy outcomes were ...
1. Chlorfenapyr LLINs provided significantly better protection than pyriproxyfen and piperonyl-butoxide subtypes. 2. Chlorfenapyr LLINs costed an additional $19 US ...
1. Vaccine efficacy at 6 months for R21/MM was 74% in group 1 and 77% in group 2. 2. R21/MM ...
Image: PD 1. African populations residing in hyperendemic and holoendemic areas were reduced from 218.6 million in 2000 to 183.5 ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.